TRAJ42 and cancer: The bias toward TRAJ42 use and conservation of a semi-invariant motif makes it tempting to speculate that the cells we describe across multiple donors likely exhibit limited antigen diversity and might bind to an identical MR1-bound cargo at the cancer cell surface.